Sammenlign metoder
Gennemgå dine valgte metoder side om side; rækker, der afviger, er fremhævet.
| Bayesiansk Placebo-test× | Bayesiansk syntetisk kontrolmetode× | |
|---|---|---|
| Fagområde | Kausal inferens | Kausal inferens |
| Familie | Regression model | Regression model |
| Oprindelsesår≠ | 2010-2015 | 2015 (Bayesian formulation); 2003 (original SCM by Abadie & Gardeazabal) |
| Ophavsperson≠ | Brodersen, Gallusser, Koehler, Remy & Scott (Bayesian causal impact context); Abadie, Diamond & Hainmueller (placebo permutation tradition) | Brodersen, Gallusser, Koehler, Remy & Scott; building on Abadie, Diamond & Hainmueller |
| Type≠ | Robustness check / falsification test | Bayesian causal inference / synthetic control |
| Oprindelig kilde | Brodersen, K. H., Gallusser, F., Koehler, J., Remy, N., & Scott, S. L. (2015). Inferring causal impact using Bayesian structural time-series models. Annals of Applied Statistics, 9(1), 247-274. DOI ↗ | Brodersen, K. H., Gallusser, F., Koehler, J., Remy, N., & Scott, S. L. (2015). Inferring causal impact using Bayesian structural time-series models. Annals of Applied Statistics, 9(1), 247-274. DOI ↗ |
| Aliasser | Bayesian falsification test, Bayesian permutation placebo, Bayesian robustness check, Bayesian in-time placebo | Bayesian SCM, Bayesian synthetic controls, probabilistic synthetic control, Bayesian SC |
| Relaterede | 5 | 5 |
| Resumé≠ | The Bayesian Placebo Test is a falsification strategy for causal inference that applies Bayesian inference to placebo scenarios — either fake treatments in the pre-intervention period, on unaffected units, or at fictitious cut-offs — to verify that observed treatment effects cannot plausibly arise by chance or from a misspecified model. It integrates prior information and yields posterior distributions of placebo effects for direct probabilistic comparison. | The Bayesian Synthetic Control Method estimates the causal effect of an intervention on a single treated unit by constructing a probabilistic counterfactual from a weighted combination of untreated donor units. Unlike the classical SCM, it places a prior distribution over the synthetic weights, yielding full posterior uncertainty intervals for the counterfactual trajectory and the treatment effect at each post-intervention time point. |
| ScholarGateDatasæt ↗ |
|
|